{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T08:42:22Z","timestamp":1698309742071},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T00:00:00Z","timestamp":1156204800000},"content-version":"vor","delay-in-days":4677,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Surgical Oncology"],"published-print":{"date-parts":[[1993,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cytotoxic therapy for paediatric malignancy continues to be associated with significant mortality and morbidity. However, survival figures continue to improve despite increasingly toxic treatment protocols. Aggressive supportive care, more than any other modality, has produced a dramatic reduction in mortality during the past 30 years, and includes the appropriate management of infection, provision of adequate nutrition, and proper use of blood and blood products. The paediatric surgeon plays an integral role in the multidisciplinary team of cancer management and together with other team specialists is responsible for the planning of surgical intervention and also ensuring the safe passage of immunologically impaired patients through the additional stress of surgery. This paper details essential aspects of supportive care as commonly practiced in paediatric patients undergoing therapy and surgery.<\/jats:p>","DOI":"10.1002\/ssu.2980090603","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T09:25:25Z","timestamp":1172136325000},"page":"461-466","source":"Crossref","is-referenced-by-count":3,"title":["Supportive care of the paediatric cancer patient"],"prefix":"10.1002","volume":"9","author":[{"given":"Martin T.","family":"Corbally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,8,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80281-1"},{"key":"e_1_2_1_3_2","first-page":"837","volume-title":"Pediatric Oncology","author":"Hathorne JW","year":"1988"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00176411"},{"key":"e_1_2_1_5_2","first-page":"963","article-title":"Risk of infectious complications in well\u2010appearing children with transient neutropenia","volume":"143","author":"Alario AJ","year":"1989","journal-title":"Am J Dis Child"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-64-2-328"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608283150905"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102143240701"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(92)90379-L"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198904063201403"},{"key":"e_1_2_1_11_2","first-page":"569","volume-title":"Paediatric Oncology. Clinical Practice and Controversies","author":"Oakhill A","year":"1992"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906153202402"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791","article-title":"Granulocyte colony stimulating factor and its receptor","volume":"78","author":"Demetri GD","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_14_2","first-page":"211","volume-title":"Cancer Therapy in Children","author":"Van Eys J","year":"1983"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90416-3"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)93276-5"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.8.822"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000207545"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1978.18278160579.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood.V58.5.1007.1007","article-title":"Long\u2010term follow\u2010up of patients with leukaemia receiving platelet transfusions: Identification of a large group of patients who do not become alloimmunized","volume":"58","author":"Dutcher JP","year":"1981","journal-title":"Blood"}],"container-title":["Seminars in Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fssu.2980090603","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ssu.2980090603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T03:00:41Z","timestamp":1698202841000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ssu.2980090603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["10.1002\/ssu.2980090603"],"URL":"https:\/\/doi.org\/10.1002\/ssu.2980090603","archive":["Portico"],"relation":{},"ISSN":["8756-0437","1098-2388"],"issn-type":[{"value":"8756-0437","type":"print"},{"value":"1098-2388","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}